OptimizeRx Corp. Submits Matters for Security Holder Vote
Ticker: OPRX · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1448431
| Field | Detail |
|---|---|
| Company | Optimizerx CORP (OPRX) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
OptimizeRx is calling a shareholder vote, details TBD.
AI Summary
OptimizeRx Corp. announced on June 11, 2025, that it is submitting matters to a vote of its security holders. The filing does not specify the nature of the vote or any details regarding the matters to be voted upon.
Why It Matters
This filing indicates that OptimizeRx Corp. is seeking shareholder approval for certain corporate actions, which could impact the company's future direction or financial structure.
Risk Assessment
Risk Level: low — The filing is procedural and does not contain information about material adverse events or significant financial changes.
Key Players & Entities
- OptimizeRx Corp. (company) — Registrant
- June 11, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 260 Charles Street, Suite 302, Waltham, MA 02453 (address) — Principal executive offices
FAQ
What specific matters will OptimizeRx Corp. security holders be voting on?
The filing does not specify the exact matters to be voted on by security holders.
When is the vote scheduled to take place?
The filing does not provide a date for the security holder vote.
Has OptimizeRx Corp. provided any background information or rationale for the upcoming vote?
No, this Form 8-K filing only states that matters are being submitted for a vote and does not include supporting details or explanations.
What is the significance of the 'Submission of Matters to a Vote of Security Holders' item?
This item indicates that the company is formally notifying the SEC that it is presenting proposals or issues for decision-making by its shareholders.
Where can shareholders find more information about the matters to be voted on?
Further details regarding the matters to be voted on would typically be found in a subsequent filing, such as a proxy statement (DEF 14A), or in company communications to shareholders.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding OptimizeRx Corp (OPRX).